Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
24.01.2024 13:37:22

Abbott Laboratories Q4 Profit Increases, Inline With Estimates

(RTTNews) - Abbott Laboratories (ABT) reported a profit for its fourth quarter that increased from the same period last year in line with the Street estimates.

The company's bottom line came in at $1.59 billion, or $0.91 per share. This compares with $1.03 billion, or $0.59 per share, in last year's fourth quarter.

Excluding items, Abbott Laboratories reported adjusted earnings of $2.09 billion or $1.19 per share for the period.

Analysts on average had expected the company to earn $1.19 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.5% to $10.24 billion from $10.09 billion last year.

Abbott Laboratories earnings at a glance (GAAP) :

-Earnings (Q4): $1.59 Bln. vs. $1.03 Bln. last year. -EPS (Q4): $0.91 vs. $0.59 last year. -Analyst Estimate: $1.19 -Revenue (Q4): $10.24 Bln vs. $10.09 Bln last year.

Analysen zu Abbott Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Abbott Laboratories 110,40 -0,22% Abbott Laboratories